Literature DB >> 32851507

Senescence and autophagy in usual interstitial pneumonia of different etiology.

Florian Gallob1, Luka Brcic1, Sylvia Eidenhammer1, Florian Rumpp2, Andreas Nerlich3, Helmut Popper4.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a disease with a dismal prognosis. Currently, the causing agent(s) are poorly understood. Recent data suggest that senescence and autophagy might play a role in its development, as well as changes in metabolism due to hypoxic conditions. In this study, the expression of senescence markers in 23 cases of usual interstitial pneumonia (UIP)/IPF and UIP/chronic autoimmune diseases (UIP/AuD) was investigated. The status of autophagy was evaluated with respect to either antiinflammatory or antihypoxia function. Formalin-fixed paraffin-embedded tissues of UIP were selected for immunohistochemistry with antibodies for p21, p16, and β-galactosidase (senescence); for LC3, SIRT1, MAP1S, and pAMKα (autophagy); and for LDH and GLUT1 (metabolism). Epithelial cells in cystic remodeled areas of UIP stained for p16 and p21, p16 being more specific compared with p21. Myofibroblasts were negative in all cases. An upregulation of all four autophagy markers was seen not only in epithelia within remodeled areas and proliferating myofibroblasts, but also in bronchial epithelia and pneumocytes. Upregulated autophagy points to a compensatory mechanism for hypoxia; therefore, LDH and GLUT1 were investigated. Their expression was present in epithelia within cystic remodeling and in myofibroblasts. The cells within the remodeled areas stained for cytokeratin 5, but coexpressed TTF1, confirming their origin from basal cells of bronchioles. Within this population, senescent cells arise. Our results indicated that autophagy in UIP very likely helps cells to survive in hypoxic condition. By phagocytosis of cellular debris, they supplement their need for nutrition, and by upregulating LDH and GLUT1, they compensate for local hypoxia.

Entities:  

Keywords:  Autophagy; Cytokeratin 5; GLUT1; Hypoxia; IPF; LC3; LDH; MAP1S; Myofibroblast; Regeneration in cysts; SIRT; Senescence; TTF1; UIP; p16; pAMKα

Mesh:

Substances:

Year:  2020        PMID: 32851507      PMCID: PMC7973921          DOI: 10.1007/s00428-020-02917-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  43 in total

1.  Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet.

Authors:  P E Bunney; A N Zink; A A Holm; C J Billington; C M Kotz
Journal:  Physiol Behav       Date:  2017-03-28

2.  Glucose Transporter 1-Dependent Glycolysis Is Increased during Aging-Related Lung Fibrosis, and Phloretin Inhibits Lung Fibrosis.

Authors:  Soo Jung Cho; Jong-Seok Moon; Chang-Min Lee; Augustine M K Choi; Heather W Stout-Delgado
Journal:  Am J Respir Cell Mol Biol       Date:  2017-04       Impact factor: 6.914

3.  Idiopathic pulmonary fibrosis: update on genetic discoveries.

Authors:  Christine Kim Garcia
Journal:  Proc Am Thorac Soc       Date:  2011-05

4.  IPF lung fibroblasts have a senescent phenotype.

Authors:  Diana Álvarez; Nayra Cárdenes; Jacobo Sellarés; Marta Bueno; Catherine Corey; Vidya Sagar Hanumanthu; Yating Peng; Hannah D'Cunha; John Sembrat; Mehdi Nouraie; Swaroop Shanker; Chandler Caufield; Sruti Shiva; Mary Armanios; Ana L Mora; Mauricio Rojas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-31       Impact factor: 5.464

5.  Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo.

Authors:  Florence Debacq-Chainiaux; Jorge D Erusalimsky; Judith Campisi; Olivier Toussaint
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

6.  Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis.

Authors:  Annika Andersson-Sjöland; Carolina García de Alba; Kristian Nihlberg; Carina Becerril; Remedios Ramírez; Annie Pardo; Gunilla Westergren-Thorsson; Moisés Selman
Journal:  Int J Biochem Cell Biol       Date:  2008-03-11       Impact factor: 5.085

7.  Glucose transporter-1 distribution in fibrotic lung disease: association with [¹⁸F]-2-fluoro-2-deoxyglucose-PET scan uptake, inflammation, and neovascularization.

Authors:  Souheil El-Chemaly; Daniela Malide; Jianhua Yao; Steven D Nathan; Ivan O Rosas; William A Gahl; Joel Moss; Bernadette R Gochuico
Journal:  Chest       Date:  2013-06       Impact factor: 9.410

8.  Autoimmune symptoms in idiopathic pulmonary fibrosis: clinical significance.

Authors:  Esam Hamad Alhamad; Joseph Galindo Cal; Ahmad Amer AlBoukai; Shaffi Ahmed Shaik; Mohammed Ahmed Omair
Journal:  Clin Respir J       Date:  2014-11-03       Impact factor: 2.570

9.  Insufficient autophagy in idiopathic pulmonary fibrosis.

Authors:  Jun Araya; Jun Kojima; Naoki Takasaka; Saburo Ito; Satoko Fujii; Hiromichi Hara; Haruhiko Yanagisawa; Kenji Kobayashi; Chikako Tsurushige; Makoto Kawaishi; Noriki Kamiya; Jun Hirano; Makoto Odaka; Toshiaki Morikawa; Stephen L Nishimura; Yoshinori Kawabata; Hiroshi Hano; Katsutoshi Nakayama; Kazuyoshi Kuwano
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-10-19       Impact factor: 5.464

10.  Dysregulated expression of hypoxia-inducible factors augments myofibroblasts differentiation in idiopathic pulmonary fibrosis.

Authors:  Arnoldo Aquino-Gálvez; Georgina González-Ávila; Laura Lorena Jiménez-Sánchez; Héctor Aquiles Maldonado-Martínez; José Cisneros; Fernanda Toscano-Marquez; Manuel Castillejos-López; Luz María Torres-Espíndola; Rafael Velázquez-Cruz; Víctor Hugo Olivera Rodríguez; Edgar Flores-Soto; Héctor Solís-Chagoyán; Carlos Cabello; Joaquín Zúñiga; Yair Romero
Journal:  Respir Res       Date:  2019-06-24
View more
  1 in total

1.  Lung fibrosis in autoimmune diseases and hypersensitivity: how to separate these from idiopathic pulmonary fibrosis.

Authors:  Helmut Popper; Elvira Stacher-Priehse; Luka Brcic; Andreas Nerlich
Journal:  Rheumatol Int       Date:  2021-10-04       Impact factor: 3.580

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.